IT8423998A0 - Coniugati risultanti e relative metodo per la preparazione di composizioni terapeuticamente coniugati della attive. adenina-9-beta-d-arabino furano-side 5' monofosfato con albumina umana lattosaminata, - Google Patents

Coniugati risultanti e relative metodo per la preparazione di composizioni terapeuticamente coniugati della attive. adenina-9-beta-d-arabino furano-side 5' monofosfato con albumina umana lattosaminata,

Info

Publication number
IT8423998A0
IT8423998A0 IT8423998A IT2399884A IT8423998A0 IT 8423998 A0 IT8423998 A0 IT 8423998A0 IT 8423998 A IT8423998 A IT 8423998A IT 2399884 A IT2399884 A IT 2399884A IT 8423998 A0 IT8423998 A0 IT 8423998A0
Authority
IT
Italy
Prior art keywords
therapeuticly
furano
arabino
monophosphate
adenine
Prior art date
Application number
IT8423998A
Other languages
English (en)
Other versions
IT1177381B (it
IT8423998A1 (it
Inventor
Luigi Fiume
Corrado Busi
Alessandro Mattioli
Massimo Baldacci
Original Assignee
Baldacci Lab Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baldacci Lab Spa filed Critical Baldacci Lab Spa
Publication of IT8423998A0 publication Critical patent/IT8423998A0/it
Priority to IT23998/84A priority Critical patent/IT1177381B/it
Priority to CA000497300A priority patent/CA1252719A/en
Priority to AT85115802T priority patent/ATE48612T1/de
Priority to US06/807,657 priority patent/US4794170A/en
Priority to DE198585115802T priority patent/DE184838T1/de
Priority to EP85115802A priority patent/EP0184838B1/en
Priority to JP60278843A priority patent/JPH0633320B2/ja
Priority to DE8585115802T priority patent/DE3574707D1/de
Priority to AU51186/85A priority patent/AU576923B2/en
Priority to ES549828A priority patent/ES8704945A1/es
Publication of IT8423998A1 publication Critical patent/IT8423998A1/it
Application granted granted Critical
Publication of IT1177381B publication Critical patent/IT1177381B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
IT23998/84A 1984-12-11 1984-12-11 Metodo per la preparazione di coniugati della adenina-9-beta-d-arabino furano-side 5' monofosfato con albumina umana lattosaminata, coniugati risultanti e relative composizioi terapeuticamente attive IT1177381B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IT23998/84A IT1177381B (it) 1984-12-11 1984-12-11 Metodo per la preparazione di coniugati della adenina-9-beta-d-arabino furano-side 5' monofosfato con albumina umana lattosaminata, coniugati risultanti e relative composizioi terapeuticamente attive
CA000497300A CA1252719A (en) 1984-12-11 1985-12-10 METHOD FOR THE PREPARATION OF CONJUGATES OF ADENINE-9- .beta.-ARABINOFURANOSIDE 5' MONOPHOSPHATE WITH LACTOSAMINATED HUMAN ALBUMIN, THE CONJUGATES OBTAINED AND THERAPEUTICALLY ACTIVE COMPOSITION CONTAINING THEM
DE198585115802T DE184838T1 (de) 1984-12-11 1985-12-11 Konjugate von adenin-9-beta-arabinofuranosid-5'-monophosphat mit menschlichem lactosaminiertem albumin, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
US06/807,657 US4794170A (en) 1984-12-11 1985-12-11 Method for the preparation of conjugates of adenine-9-beta-arabinofuranoside 5' monophosphate with lactosaminated human albumin, the obtained conjugates and therapeutically active compositions containing them
AT85115802T ATE48612T1 (de) 1984-12-11 1985-12-11 Konjugate von adenin-9-beta-arabinofuranosid-5'monophosphat mit menschlichem lactosaminiertem albumin, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
EP85115802A EP0184838B1 (en) 1984-12-11 1985-12-11 Conjugates of adenine-9-beta-arabinofuranoside 5' monophosphate with lactosaminated human albumin, a method for their preparation and therapeutically active compositions containing them
JP60278843A JPH0633320B2 (ja) 1984-12-11 1985-12-11 ラクトサミン化ヒトアルブミンとアデニン―9―β―D―アラビノフラノシド5′モノホスフェートの結合体の製造方法
DE8585115802T DE3574707D1 (de) 1984-12-11 1985-12-11 Konjugate von adenin-9-beta-arabinofuranosid-5'-monophosphat mit menschlichem lactosaminiertem albumin, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
AU51186/85A AU576923B2 (en) 1984-12-11 1985-12-11 Conjugates of adenine-9-beta-arabinofuranoside-5- monophosphate and lactosaminated human albumin
ES549828A ES8704945A1 (es) 1984-12-11 1985-12-11 Procedimiento de preparar conjugados de adentina 9-beta-d-arabinofuranosido 5' monofosfato con albumina humana lactosaminada.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23998/84A IT1177381B (it) 1984-12-11 1984-12-11 Metodo per la preparazione di coniugati della adenina-9-beta-d-arabino furano-side 5' monofosfato con albumina umana lattosaminata, coniugati risultanti e relative composizioi terapeuticamente attive

Publications (3)

Publication Number Publication Date
IT8423998A0 true IT8423998A0 (it) 1984-12-11
IT8423998A1 IT8423998A1 (it) 1986-06-11
IT1177381B IT1177381B (it) 1987-08-26

Family

ID=11211397

Family Applications (1)

Application Number Title Priority Date Filing Date
IT23998/84A IT1177381B (it) 1984-12-11 1984-12-11 Metodo per la preparazione di coniugati della adenina-9-beta-d-arabino furano-side 5' monofosfato con albumina umana lattosaminata, coniugati risultanti e relative composizioi terapeuticamente attive

Country Status (9)

Country Link
US (1) US4794170A (it)
EP (1) EP0184838B1 (it)
JP (1) JPH0633320B2 (it)
AT (1) ATE48612T1 (it)
AU (1) AU576923B2 (it)
CA (1) CA1252719A (it)
DE (2) DE184838T1 (it)
ES (1) ES8704945A1 (it)
IT (1) IT1177381B (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1207507B (it) * 1985-10-21 1989-05-25 Baldacci Lab Spa Coniugato della 9-(2-idrossietossimetil)guanina con albumina umana lattosaminata, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono.
US5554386A (en) * 1986-07-03 1996-09-10 Advanced Magnetics, Inc. Delivery of therapeutic agents to receptors using polysaccharides
IT1245217B (it) * 1991-03-12 1994-09-13 Baldacci Lab Spa Coniugato di azidotimidina ed albumina umana procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
IT1256110B (it) * 1992-11-23 1995-11-28 Procedimento di coniugazione di nucleosidi antivirali con albumina umana lattosaminata
ITMI20010027A1 (it) * 2001-01-10 2002-07-10 Uni Di Bologna Dipartimento Di Composizioni teraputiche per una chemioterapia locoregionale non invasiva delle micrometastasi epatiche
ATE411819T1 (de) * 2003-02-17 2008-11-15 Upperton Ltd Konjugate für medizinische abbildungen umfassend träger, targeting-anteile und kontrastmittel

Also Published As

Publication number Publication date
CA1252719A (en) 1989-04-18
AU5118685A (en) 1986-06-19
ATE48612T1 (de) 1989-12-15
ES8704945A1 (es) 1987-05-01
DE3574707D1 (de) 1990-01-18
AU576923B2 (en) 1988-09-08
ES549828A0 (es) 1987-05-01
IT1177381B (it) 1987-08-26
IT8423998A1 (it) 1986-06-11
EP0184838B1 (en) 1989-12-13
JPS61171430A (ja) 1986-08-02
EP0184838A3 (en) 1987-04-29
EP0184838A2 (en) 1986-06-18
US4794170A (en) 1988-12-27
DE184838T1 (de) 1987-03-19
JPH0633320B2 (ja) 1994-05-02

Similar Documents

Publication Publication Date Title
DK151985D0 (da) Humant fysiologisk aktivt polypeptid
DE3689246T2 (de) Physiologisch aktives Polypeptid BUF-3.
IT1163001B (it) Procedimento per la preparazione di 4' epidaunorubicina 3', 4' diepidaunorubicina e corrispondenti analoghi della doxorubicina
IT8521088A0 (it) Procedimento per la preparazione di 1,2-difluoroetilene e 1-cloro-1,2-difluoro-etilene.
IT8521763A0 (it) Procedimento per la preparazione di derivati 3-sostituiti dall'1-amino-2-idrossi-propano.
IT8421622A0 (it) Procedimento per la preparazione di peptidi.
IT8521002A0 (it) 4' -desclororebeccamicina eprocedimento per la sua preparazione.
IT8423998A0 (it) Coniugati risultanti e relative metodo per la preparazione di composizioni terapeuticamente coniugati della attive. adenina-9-beta-d-arabino furano-side 5' monofosfato con albumina umana lattosaminata,
IT8419141A0 (it) Procedimento per la preparazione dell'estere metilico di alfa-l-aspartil-l-fenilalanina.
IT8521570A0 (it) Procedimento di preparazione di microlattici invertiti ed i microlattici invertiti ottenuti.
IT9020020A0 (it) "n,n'-ditrimetossibenzoilpiperazine 2-sostituite, procedimento per la loro preparazione e composizioni terapeutiche che le contengono
IT8423896A0 (it) Diacilderivati della glicerilfosforilcolina ad attivita' terapeutica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
IT1230068B (it) Procedimento per la preparazione di n sulfoniluree.
IT8619206A0 (it) Procedimento per la preparazione di 4,4-dialchil-2-azetidinoni.
ES546387A0 (es) Procedimiento pra la preparacion de 1,4-dihidropiridinas sustituidas,opticamente activas
IT8421523A0 (it) Procedimento per la preparazione di 4'-epidoxorubicina.
IT1230856B (it) Procedimento per la preparazione di metil 3 amminocrotonato.
IT8420456A0 (it) Procedimento per la preparazione di polifenileteri.
IT8919633A0 (it) Procedimento per la preparazione di enzima mieloperossidasi.
IT8419018A0 (it) Composizione farmaceutica a base di n-acil fosfatidiletanolammina, procedimento per la preparazione della stessa, specialita'farmaceutica e uso della stessa.
IT8519115A0 (it) Derivato della piparazina, procedimento per la sua preparazione e composizione farmaceutica.
IT8422633A0 (it) Aril-alchil-piperazine farmaceuticamente attive, procedimenti per la loro preparazione e composizioni relative.
IT1190889B (it) Procedimento perfezionato per la preparazione della 2,4-diammino-5-(3',4',5',trimetossibenzil)-pirimidina
IT8423535A0 (it) Procedimento per la preparazione di composizioni cosmetiche medicinali.
IT8523243A0 (it) Preparazioni, principalmente preparazioni di pasticceria che riducono l'incidenza della carie dentale e procedimenti per preparare dette preparazioni.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19961227